[ Price : $8.95]
Novocure says its Phase 3 ENGOT-ov50/GOG-3029/INNOVATE-3 clinical trial of Tumor Treating Fields together with paclitaxel in patie...[ Price : $8.95]
Federal Register notice: FDA makes available a final guidance entitled Enhanced Drug Distribution Security Requirements Under Sect...[ Price : $8.95]
FDA posts a guidance on new enforcement deferments affecting enhanced drug distribution security requirements.[ Price : $8.95]
Inmar Supply Chain Solutions recalls FDA-regulated products (over-the-counter (OTC) human or animal drugs, OTC medical devices, di...[ Price : $8.95]
CDER asks for comments on its proposal to withdraw Oncopeptides accelerated-approved multiple myeloma drug Pepaxto (melphalan fluf...[ Price : $8.95]
CDRH announces the qualification of a new tool through the agencys voluntary Medical Device Development Tools program: Accelerated...[ Price : $8.95]
FDA clears a Fresenius Medical Care 510(k) for VersiHD with GuideMe Software, a self-guided interface for the companys VersiHD chr...[ Price : $8.95]
FDA grants Redx an orphan drug designation for zelasudil (RXC007) for treating idiopathic pulmonary fibrosis.